Charles A. Raffin, MBA – Principal

Mr. Raffin has 15 years in biopharmaceuticals and nearly 20 years in clinical diagnostics. In 2010, he retired from Johnson & Johnson as Vice President, Commercial Assessment, Worldwide Franchise Development and is currently utilizing his unique combination of backgrounds to help understand the promise of personalized medicine where companion diagnostics enable more effective drug selection decisions. After starting out as a Hematology and Blood Bank Supervisor, Mr. Raffin transitioned to Sales, Marketing and Business Development positions at numerous levels in both the drug and diagnostic product groups in the J&J family of companies. His experiences created strategic commercial expertise in oncology, hematology, anemia management, and capital equipment for labs, blood typing and transfusion safety, point of care devices, molecular diagnostics, organ transplantation, OB-GYN, HIV and cardio-metabolic disease diagnostics. Mr. Raffin covered several diagnostic product areas and provided leadership in worldwide biopharmaceutical sales and marketing for Erythropoiesis Stimulating Agents (EPO), organ transplant rejection and Rh Immune Globulin including involvement with products at every stage of lifecycle including earliest product concept assessments, line extension strategies and several product launches and recalls in both domestic and international environments. He has been an invited advisory board member and speaker at several industry events and has conducted multiple market research initiatives and Payer Advisory Boards, presenting and moderating Opinion Leader discussions. Mr. Raffin holds a BS in Medical Technology from Wayne State University in Detroit, Michigan and an MBA from University of Michigan in Ann Arbor, Michigan.

< Back to Team